Foresite Capital Management VI’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.92M Buy
2025
Q1
$5.03M Hold
2024
Q4
$8.46M Buy